Table 1

Baseline characteristics of incident type 2 diabetes cases and matched controls, the Singapore Chinese Health Study*

Cases
(n=254)
Controls
(n=254)
P value†
Age (years) at blood taken59.0±5.8359.3±6.03
Gender (female)134 (52.8)134 (52.8)
Dialect (%)
 Cantonese127 (50.0)127 (50.0)
 Hokkien127 (50.0)127 (50.0)
Body mass index (kg/m2)24.8±3.6822.6±3.41<0.001
Level of education (%)0.84
 No formal education31 (12.2)34 (13.4)
 Primary school117 (46.1)111 (43.7)
 Secondary and above106 (41.7)109 (42.9)
History of hypertension (%)127 (50.0)57 (22.4)<0.001
Cigarette smoking (%)0.57
 Never smokers177 (70.0)178 (70.1)
 Former smoker34 (13.4)40 (15.8)
 Current smokers43 (16.9)36 (14.2)
Weekly moderate-to-vigorous activity (%)0.004
 <0.5 hours/week199 (78.4)196 (77.2)
 0.5–3.9 hours/week44 (17.3)29 (11.4)
 ≥4 hours/week11 (4.3)29 (11.4)
Alcohol intake (%)0.95
 Abstainers223 (87.8)223 (87.8)
 Weekly drinkers25 (9.8)24 (9.5)
 Daily drinkers6 (2.4)7 (2.8)
Fasting status (yes)75 (29.5)68 (26.8)0.49
ELF score, µg/L9.28±0.719.18±0.690.12
TIMP1, µg/L227.9±39.0213.5±35.6<0.001
PIIINP, µg/L7.56±2.697.01±2.750.023
HA, µg/L69.6±67.068.8±76.80.90
GGT, IU/L31 (21–46)23 (17–35)<0.001
ALT, IU/L25 (19–36)20 (15–27)<0.001
HDL-C, mmol/L1.08±0.261.23±0.31<0.001
TG, mmol/L2.1 (1.4–2.8)1.5 (1.0–2.0)<0.001
Adiponectin, µg/mL7.26±3.019.09±3.57<0.001
hs-CRP, mg/L1.6 (0.9–3.2)1.2 (0.6–2.1)<0.001
HbA1c, %5.90±0.355.53±0.27<0.001
  • *Data are expressed as mean±SD for continuous variables (normally distributed) and median (IQR) for continuous variables (skewed distributed), and n (percentage) for categorical variables. Cases and controls are matched on age at blood taken (±3 years), gender, dialect and date of blood collection (±6 months).

  • †P values based on the χ2 test for categorical variables, student’s t-test for continuous variable with normal distribution and Mann-Whitney U test for continuous variable with skewed distribution.

  • ALT, alanine aminotransferase; ELF, enhanced liver fibrosis; GGT, gamma-glutamyl transferase; HA, hyaluronic acid; HbA1c, hemoglobin A1c; HDL-C, high-density lipoprotein cholesterol; hs-CRP, high-sensitivity C reactive protein; PIIINP, amino-terminal propeptide of type III procollagen; TG, triglycerides; TIMP1, tissue inhibitor of matrix metalloproteinase 1.